Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells.
about
Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patientsThe synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cellsHerpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human DiseaseUpregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator ZtaRequirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.The Epstein-Barr virus and its association with human cancers.Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancerEpstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol)Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cellsUse of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytesTranscriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsEpstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa.(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cellsFeatures distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases.Expression of the Epstein-Barr virus BHRF1 gene, a homologue of Bcl-2, in nasopharyngeal carcinoma tissue.The ecology and pathology of Epstein-Barr virus.Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas.Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells.Association of Epstein-Barr virus and nasopharyngeal carcinoma in Caucasian patients.Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma.Proper use of serum antibody titres against Epstein-Barr virus in nasopharyngeal carcinoma: IgA/virus capsid antigen for diagnosis and EBV-related nuclear antigen-2 for follow-up.Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation with patient response to therapy.Epstein-Barr virus infections and their association with human malignancies: some key questions.EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies.Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma.
P2860
Q24800020-B4171F17-1ABA-453C-B978-8A24F0A9F990Q28483778-A0BD582E-ECB8-438A-A2F4-97EBF272C663Q31152067-92AB353F-E8A7-467E-8B2B-AFCF4DEACA41Q33809585-56DDBAE1-DA6A-4ACB-9329-1BACEAB46675Q33821583-0595952C-17B7-4219-9BF3-8CEF7C707ECBQ33882153-128AC214-08CD-405E-8752-C83AE0E9D8FFQ34123922-201FBF93-1738-4F91-B6D2-88A59B6F0747Q34226611-715143B4-C6C4-4D3B-AEDD-361293C913DEQ34261764-E25E5AC1-6367-4856-AB23-C0C9FC6E02A1Q34301695-4ADF950A-FC13-4639-BB4B-E60D0F18BB6BQ34302078-30C9BF09-D0D9-4392-AB2F-55C2EBD6E723Q34350013-63D5B3B3-B5C6-42AF-BAD0-2B1EF4633AF0Q34483687-03BD9BC6-E52A-4EF2-A6C4-64A70CB26C05Q34586675-C3D4702D-38EE-4B6A-81E6-D40FDF5BF795Q35077651-0A8E190E-42E0-4220-9AF0-C3FFF110214EQ36135900-B0DDE4D7-7420-4835-9586-159956465156Q36498181-AEAB07ED-6DDA-4FF4-A53C-74C2DB7A6203Q36648185-9B16DC73-1217-458A-A5BC-45BFE182C49FQ38296954-313AB576-B268-4311-83CC-C23B370719BFQ39034599-7145A653-DD41-4424-B8D0-45394A6333B5Q39238849-08EFA68C-6955-4B20-ADFF-F962BCAB305FQ39578660-6DEABEF5-A214-43F6-BA53-12CA52FCF6DCQ39852028-F6480146-718C-4A4B-9B16-649790042695Q40794736-9CB3B55E-82A8-4458-BB18-6E48D15E95C2Q40882195-AC44B07C-FAB7-4265-9E21-7DB81087CB3DQ41036904-86EE8863-CE2A-43EC-AAEB-0675E2EB8202Q42019706-753BDC50-052A-49C8-ACFB-675019C52B36Q42197461-DA5E4E3E-5076-4E68-97FB-3BB2CC920E98Q43206312-844FE810-707F-4EF9-9918-0B161A142CBFQ45733184-7D90DFEE-3C0B-4066-BFA3-4DC0D46652C0Q45734089-B7D5A1E5-899B-4DA9-A53C-CA9FC0DAC244Q45742868-EFD442AA-D97E-426E-957A-1F920854C7BAQ45750690-464BB885-B88C-4221-9C4C-D4F3E3E01B56Q45754627-E0C4C7D0-7F39-447D-BC8C-65D6682E32B8Q54221806-2BCA0441-18E4-4BB7-980F-93F8A3A1DBEFQ55313422-A221140A-17B1-4487-AABF-6E0808851B33
P2860
Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Expression of the Epstein-Barr ...... ryngeal carcinoma tumor cells.
@en
type
label
Expression of the Epstein-Barr ...... ryngeal carcinoma tumor cells.
@en
prefLabel
Expression of the Epstein-Barr ...... ryngeal carcinoma tumor cells.
@en
P2093
P356
P1433
P1476
Expression of the Epstein-Barr ...... ryngeal carcinoma tumor cells.
@en
P2093
Bernaudin JF
Grunewald V
Martel-Renoir D
P304
P356
10.1006/VIRO.1993.1597
P407
P577
1993-11-01T00:00:00Z